Literature DB >> 7640450

Changes in serum myosin light chain I following aortocoronary bypass operations.

M Yamamuro1, K Takazawa, M Tahara, S Sasaguri, M Nukariya, Y Hosoda.   

Abstract

The changes in myosin light chain I (MLC I) following aortocoronary bypass were studied in 31 patients and the curves of these changes were classified into three different patterns. A peak level of 14.7 +/- 1.54 ng/ml was seen in seven patients on postoperative day (POD) 2 which decreased suddenly to less than twice the normal value by POD 7 (group 1). Another 19 patients showed a peak level of 20.7 +/- 16.5 ng/ml on POD 5, which decreased slowly and was still high even by POD 7 (group 2). The remaining five patients developed only a slight increase in the MLC I level after the operation, with a peak value of 5.5 +/- 0.8 ng/ml (group 3). Creatine kinase myocardial band and glutamic oxaloacetic transaminase also remained low in this group. No correlation existed between the peak value of MLC I and the aortic cross-clamping time, or between the peak value of MLC I and the cardiopulmonary bypass time. Furthermore, the difference in cardiac output before and after the operation did not significantly differ among the three groups. These findings indicate that the measurement of MLC I is useful for diagnosing perioperative myocardial damage and may also be useful in the study of myocardial protection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7640450     DOI: 10.1007/bf00311531

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  12 in total

1.  Changes in serum CK-MB mass after coronary artery bypass surgery.

Authors:  F Van Lente; A M McHugh; R S Galen
Journal:  Clin Biochem       Date:  1987-10       Impact factor: 3.281

2.  Operative myocardial protection: does an elevated level of creatine phosphokinase-MB isoenzyme always indicate myocardial necrosis?

Authors:  P R Brown; R C Chiu
Journal:  Can J Surg       Date:  1984-01       Impact factor: 2.089

3.  Interpretation of changes in the activity of creatine kinase MB isoenzyme in serum after coronary artery bypass grafting.

Authors:  S Y Farah; D W Moss; P Ribeiro; C M Oakley; R N Sapsford
Journal:  Clin Chim Acta       Date:  1984-08-31       Impact factor: 3.786

4.  Early enzyme release from myocardial cells is not due to irreversible cell damage.

Authors:  H M Piper; P Schwartz; R Spahr; J F Hütter; P G Spieckermann
Journal:  J Mol Cell Cardiol       Date:  1984-04       Impact factor: 5.000

5.  Radioimmunoassay of cardiac myosin light chain II in the serum following experimental myocardial infarction.

Authors:  R Nagai; S Ueda; Y Yazaki
Journal:  Biochem Biophys Res Commun       Date:  1979-02-14       Impact factor: 3.575

6.  Assessment of myocardial infarct size by serial changes in serum cardiac myosin light chain II in dogs.

Authors:  R Nagai; Y Yazaki
Journal:  Jpn Circ J       Date:  1981-06

7.  The quantitation of human ventricular myosin light chain 1 in serum after myocardial necrosis and infarction.

Authors:  J X Wang; Q W Shi; T W Wu; G Jackowski; D A Mickle
Journal:  Clin Chim Acta       Date:  1989-05-31       Impact factor: 3.786

8.  CK-MB release following coronary artery bypass grafting in the absence of myocardial infarction.

Authors:  M E Lee; D H Sethna; C M Conklin; W E Shell; J M Matloff; R J Gray
Journal:  Ann Thorac Surg       Date:  1983-03       Impact factor: 4.330

9.  Measurement of human ventricular myosin light chain-1 by monoclonal solid-phase enzyme immunoassay in patients with acute myocardial infarction.

Authors:  Y Uji; H Sugiuchi; H Okabe
Journal:  J Clin Lab Anal       Date:  1991       Impact factor: 2.352

10.  Diagnosis of acute myocardial infarction by detection of circulating cardiac myosin light chains.

Authors:  H A Katus; T Yasuda; H K Gold; R C Leinbach; H W Strauss; C Waksmonski; E Haber; B A Khaw
Journal:  Am J Cardiol       Date:  1984-11-01       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.